2025-07-15 - Analysis Report
Okay, here's the analysis of TG Therapeutics Inc. (TGTX) based on the provided data, presented with numbers first, followed by an interpretation.

## TG Therapeutics Inc. (TGTX) Analysis

**Company Overview:** TG Therapeutics Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance vs. S&P 500 (VOO)

*   **TGTX Cumulative Return:** 72.86%
*   **VOO Cumulative Return:** 95.85%
*   **Absolute Divergence:** -28.9%
*   **Divergence Range:** (Max: 401.1, Min: -110.5)
*   **Relative Divergence:** 15.9

**Analysis:** TGTX has underperformed the S&P 500 (VOO) over the period covered by the cumulative return calculation. The relative divergence of 15.9 suggests that TGTX's current underperformance is near the lower end of its historical divergence range compared to the VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha  | Beta  | Cap(B) |
|------------|--------|-------|--------|-------|--------|
| 2015-2017  | -6.0%  | 56.5% | -35.0% | -0.1  | 1.3    |
| 2016-2018  | -8.0%  | 58.6% | -26.0% | 0.0   | 0.7    |
| 2017-2019  | 74.0%  | 58.6% | 44.0%  | 0.0   | 1.8    |
| 2018-2020  | 402.0% | 58.6% | 382.0% | -0.4  | 8.3    |
| 2019-2021  | 125.0% | 63.5% | 76.0%  | -0.5  | 3.0    |
| 2020-2022  | -76.0% | 70.4% | -78.0% | -0.6  | 1.9    |
| 2021-2023  | -350.0%| 70.4% | -368.0%| -0.8  | 2.7    |
| 2022-2024  | 71.0%  | 73.1% | 45.0%  | -0.9  | 4.8    |
| 2023-2025  | 80.0%  | 73.1% | 32.0%  | 0.4   | 6.2    |

**Analysis:**

*   **CAGR Volatility:** The CAGR (Compound Annual Growth Rate) fluctuates significantly, indicating high volatility in TGTX's performance over different periods.
*   **High MDD:** The Maximum Drawdown (MDD) values are consistently high, suggesting substantial risk and potential for significant losses.
*   **Inconsistent Alpha:** The Alpha values vary widely, sometimes significantly positive (outperforming the benchmark) and sometimes strongly negative (underperforming the benchmark).
*   **Beta Instability:** The Beta values are generally unstable, indicating variable correlation with the market. In some periods it is negative, meaning the stock moves opposite to the market

### 2. Recent Stock Price Movements

*   **Current Price:** \$38.92
*   **Previous Close:** \$37.085
*   **Change:** 4.95%
*   **5-Day Moving Average:** 37.861
*   **20-Day Moving Average:** 36.665
*   **60-Day Moving Average:** 37.1483

**Analysis:**

*   The current price is above all three moving averages (5, 20, and 60-day), indicating a short-term upward trend.
*   The significant price increase (4.95%) from the previous close suggests a strong positive movement.

### 3. Technical Indicators and Expected Return

*   **MRI (Market Risk Indicator):** 0.3372 (Low Risk)
*   **RSI (Relative Strength Index):** 61.04
*   **PPO (Percentage Price Oscillator):** 0.5479
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (1 shares - Safe)
*   **Recent (20-day) Relative Divergence Change:** 0.8 (+) - Short-term increase
*   **Expected Return:** -245.3% (vs. S&P 500, long-term)

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests a low-risk environment.
*   **RSI:** An RSI of 61.04 indicates the stock is approaching overbought territory.
*   **PPO:** The positive PPO suggests a positive momentum.
*   **Hybrid Signal:** The buy signal indicates a bullish outlook based on the hybrid model.
*   **Divergence Change:** The recent increase in relative divergence suggests the stock has been outperforming the S&P 500 recently.
*   **Expected Return:** The highly negative expected return indicates significant potential underperformance compared to the S&P 500 in the long term.
*   **Price Change Impact:** The significant price change of 4.95% indicates a notable event driving investor sentiment, possibly linked to news or company announcements.

### 4. Recent News & Significant Events

*   **[2025-07-11]:** Major business developments, regulatory changes, or market events.
*   **[2025-07-15]:** Analyst discussions on recent performance and outlook.
*   **[2025-07-14]:** Stock volatility influenced by recent news, earnings, or executive actions.
*   **[2025-07-13]:** Market experts highlight risks and opportunities, advising monitoring of news and announcements.

**Analysis:** The news highlights recent events influencing the stock's volatility, including potential business developments, regulatory changes, and analyst discussions. Investors should monitor news closely for specific catalysts.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-05-09 | 0.03  | 0.12 B\$ |
| 2024-11-07 | 0.03  | 0.08 B\$ |
| 2024-08-09 | 0.05  | 0.07 B\$ |
| 2024-05-06 | -0.07 | 0.06 B\$ |
| 2025-05-09 | -0.07 | 0.06 B\$ |

**Analysis:**

*   Recent earnings have shown fluctuations in EPS. The most recent report shows a move to positive EPS of 0.03, suggesting improvement.
*   Revenue has shown a general upward trend, but may have seasonal variance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-03-31 | \$0.12B | 87.14%        |
| 2024-12-31 | \$0.11B | 85.77%        |
| 2024-09-30 | \$0.08B | 88.86%        |
| 2024-06-30 | \$0.07B | 88.70%        |
| 2024-03-31 | \$0.06B | 91.43%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE     |
|------------|---------|---------|
| 2025-03-31 | \$0.24B | 2.13%   |
| 2024-12-31 | \$0.22B | 10.49%  |
| 2024-09-30 | \$0.19B | 2.02%   |
| 2024-06-30 | \$0.18B | 3.87%   |
| 2024-03-31 | \$0.16B | -6.69%  |

**Analysis:**

*   **Revenue Trend:**  Revenue has generally increased over the past year, indicating growth in sales.
*   **High Profit Margins:** Profit margins are consistently high, indicating efficient cost management and pricing strategies.
*   **Equity Growth:** Equity has steadily increased, suggesting improved financial stability and reinvestment of earnings.
*   **ROE Volatility:** Return on Equity (ROE) has fluctuated, with a notable increase in the last quarter, indicating varying profitability relative to shareholder equity.

### 7. Overall Analysis and Summary

TGTX shows a mixed picture. While there are positive indicators like increasing revenue, high profit margins, recent earnings improvements, and a current upward price trend, there are significant concerns. The stock has underperformed the S&P 500, exhibits high historical volatility and risk (MDD), and is projected to underperform significantly in the long term.

**Key Takeaways:**

*   **Short-Term Bullish, Long-Term Bearish:** Recent price action and some technical indicators suggest short-term positive momentum, but the long-term outlook based on expected return is negative.
*   **High Risk:** The high MDD and volatile CAGR indicate substantial risk.
*   **Monitor News:** Recent news events are influencing the stock's movement, requiring close monitoring.
*   **Financial Improvements:** The increasing revenue, high profit margins, and positive EPS are positive signs.
*   **Contradictory Signals:** The Hybrid Signal indicates a buy recommendation, while the expected return is highly negative.

**Recommendation:**

Given the contradictory signals and high risk, a cautious approach is warranted. While the short-term trend might be positive, the long-term underperformance projection and high volatility make this a speculative investment. Investors should conduct thorough due diligence, closely monitor company news and financial performance, and carefully consider their risk tolerance before investing. The negative expected return suggests that there might be better investment opportunities elsewhere.
